Web Stats Provided By Google Analytics

Thursday, May 16, 2013

SIMPONI (GOLIMUMAB) Receives FDA Approval for Ulcerative Colitis

First and Only Subcutaneous Biologic Treatment Approved to Induce and Maintain Clinical Response and Improve Endoscopic Appearance of the Mucosa During Induction Horsham, PA, - Janssen Biotech, Inc.

http://www.webwire.com/ViewPressRel.asp?aId=174758

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts